8850 Starts
- 3225
- -20-0.62%
Starts News
BofA Securities Starts Akamai Technologies at Buy With $145 Price Target
Craig-Hallum Starts ScPharmaceuticals at Buy With $20 Price Target
Barclays Starts Jabil With Overweight Rating, Price Target Is $134
B. Riley Starts Repro Med Systems at Buy With $4.50 Price Target, Says Risk/Reward Becoming More Favorable
Baird Starts Lucid Group at Neutral With $7 Price Target
Jones Trading Starts Prime Medicine at Buy With $20 Price Target
HSBC Starts Biogen With Buy Rating, Price Target Is $360
Northland Starts Clean Energy Fuels at Outperform With $7.50 Price Target
BofA Securities Starts Mid-America Apartment Communities at Neutral With $158 Price Target
Citigroup Starts Sana Biotechnology at Buy With $8 Price Target
BMO Capital Starts Duckhorn Portfolio at Market Perform, $14 Price Target
Raymond James Starts Ferguson at Outperform With $175 Price Target
Canaccord Genuity Starts Confluent at Buy With $40 Price Target
Needham Starts MoonLake Immunotherapeutics at Buy With $76 Price Target
Truist Securities Starts RadNet at Buy With $40 Price Target
BMO Capital Starts Civitas Resources at Outperform With $95 Price Target
Barclays Starts Stem at Equalweight With $6 Price Target
B. Riley Starts AZZ at Buy With $64 Price Target, Notes Leading Position as Value-Add Player
Evercore ISI Starts Gulfport Energy at Outperform With $135 Price Target
HSBC Starts Align Technology at Buy With $450 Price Target
Analysis
Price Target
No Data
